Chief Scientific Officer, Dr. R.P. Iyer presented at the NIH conference

Spring Bank Pharmaceutical’s Chief Scientific Officer, Dr. R.P. Iyer presented at the NIH conference on anti-infectives and provided status updates on the development of SB 9200 for the treatment of Hepatitis C and Hepatitis C virus infection.

Leave a reply